Biogen Alzheimer's drug may be 'first effort of a clear win': Analyst

Baird Senior Research Analyst Brian Skorney joins Yahoo Finance Live to discuss the breakthrough of Biogen's Alzheimer's drug, which is pushing the stock higher.